
The ever-evolving and contagious nature of the Coronavirus (COVID-19) has immobilized the world around us. As the daily number of infected cases increases, the containment of the spread of this virus is proving to be an overwhelming task. Healthcare facilities around the world are overburdened with an ominous responsibility to combat an ever-worsening scenario. To aid the healthcare system, Internet of Things (IoT) technology provides a better solution—tracing, testing of COVID patients efficiently is gaining rapid pace. This study discusses the role of IoT technology in healthcare during the SARS-CoV-2 pandemics. The study overviews different research, platforms, services, products where IoT is used to combat the COVID-19 pandemic. Further, we intelligently integrate IoT and healthcare for COVID-19 related applications. Again, we focus on a wide range of IoT applications in regards to SARS-CoV-2 tracing, testing, and treatment. Finally, we effectively consider further challenges, issues, and some direction regarding IoT in order to uplift the healthcare system during COVID-19 and future pandemics.
Citation: Anichur Rahman, Muaz Rahman, Dipanjali Kundu, Md Razaul Karim, Shahab S. Band, Mehdi Sookhak. Study on IoT for SARS-CoV-2 with healthcare: present and future perspective[J]. Mathematical Biosciences and Engineering, 2021, 18(6): 9697-9726. doi: 10.3934/mbe.2021475
[1] | Fang Wang, Lianying Cao, Xiaoji Song . Mathematical modeling of mutated COVID-19 transmission with quarantine, isolation and vaccination. Mathematical Biosciences and Engineering, 2022, 19(8): 8035-8056. doi: 10.3934/mbe.2022376 |
[2] | Yangyang Yu, Yuan Liu, Shi Zhao, Daihai He . A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa. Mathematical Biosciences and Engineering, 2022, 19(10): 10361-10373. doi: 10.3934/mbe.2022485 |
[3] | Julijana Gjorgjieva, Kelly Smith, Gerardo Chowell, Fabio Sánchez, Jessica Snyder, Carlos Castillo-Chavez . The Role of Vaccination in the Control of SARS. Mathematical Biosciences and Engineering, 2005, 2(4): 753-769. doi: 10.3934/mbe.2005.2.753 |
[4] | Sarafa A. Iyaniwura, Rabiu Musa, Jude D. Kong . A generalized distributed delay model of COVID-19: An endemic model with immunity waning. Mathematical Biosciences and Engineering, 2023, 20(3): 5379-5412. doi: 10.3934/mbe.2023249 |
[5] | Tahir Khan, Roman Ullah, Gul Zaman, Jehad Alzabut . A mathematical model for the dynamics of SARS-CoV-2 virus using the Caputo-Fabrizio operator. Mathematical Biosciences and Engineering, 2021, 18(5): 6095-6116. doi: 10.3934/mbe.2021305 |
[6] | Kai Wang, Zhenzhen Lu, Xiaomeng Wang, Hui Li, Huling Li, Dandan Lin, Yongli Cai, Xing Feng, Yateng Song, Zhiwei Feng, Weidong Ji, Xiaoyan Wang, Yi Yin, Lei Wang, Zhihang Peng . Current trends and future prediction of novel coronavirus disease (COVID-19) epidemic in China: a dynamical modeling analysis. Mathematical Biosciences and Engineering, 2020, 17(4): 3052-3061. doi: 10.3934/mbe.2020173 |
[7] | Kimihito Ito, Chayada Piantham, Hiroshi Nishiura . Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark. Mathematical Biosciences and Engineering, 2022, 19(9): 9005-9017. doi: 10.3934/mbe.2022418 |
[8] | Chentong Li, Jinhu Xu, Jiawei Liu, Yicang Zhou . The within-host viral kinetics of SARS-CoV-2. Mathematical Biosciences and Engineering, 2020, 17(4): 2853-2861. doi: 10.3934/mbe.2020159 |
[9] | Salman Safdar, Calistus N. Ngonghala, Abba B. Gumel . Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States. Mathematical Biosciences and Engineering, 2023, 20(1): 179-212. doi: 10.3934/mbe.2023009 |
[10] | Junyuan Yang, Guoqiang Wang, Shuo Zhang . Impact of household quarantine on SARS-Cov-2 infection in mainland China: A mean-field modelling approach. Mathematical Biosciences and Engineering, 2020, 17(5): 4500-4512. doi: 10.3934/mbe.2020248 |
The ever-evolving and contagious nature of the Coronavirus (COVID-19) has immobilized the world around us. As the daily number of infected cases increases, the containment of the spread of this virus is proving to be an overwhelming task. Healthcare facilities around the world are overburdened with an ominous responsibility to combat an ever-worsening scenario. To aid the healthcare system, Internet of Things (IoT) technology provides a better solution—tracing, testing of COVID patients efficiently is gaining rapid pace. This study discusses the role of IoT technology in healthcare during the SARS-CoV-2 pandemics. The study overviews different research, platforms, services, products where IoT is used to combat the COVID-19 pandemic. Further, we intelligently integrate IoT and healthcare for COVID-19 related applications. Again, we focus on a wide range of IoT applications in regards to SARS-CoV-2 tracing, testing, and treatment. Finally, we effectively consider further challenges, issues, and some direction regarding IoT in order to uplift the healthcare system during COVID-19 and future pandemics.
The basic reproduction number, denoted by R0, is an index that represents the expected number of secondary cases from an infected individual during the entire period of infectiousness in a fully susceptible population [1]. This number plays a central role in measuring the transmissibility of infectious diseases and thus acts as the fundamental index for planning control strategies. During the COVID-19 epidemic, a new variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the so-called Delta variant (B.1.617), was detected in Japan in March 2021. Estimating the relative reproduction number of the variant compared with the wild type of the virus then became an urgent task. In the early phase of the Delta variant epidemic, common methodologies to estimate R0, which includes models based on exponential growth rate and generation time distribution, were difficult to implement due to a limited number of observed cases and the progress of variant replacements from Alpha (B.1.1.7) to Delta. Moreover, the spread of the Delta variant occurred in the middle of the very first vaccination campaign, from spring to summer of 2021, making it even more challenging to calculate the variant's basic reproduction number and relative transmissibility. Common methods for estimating R0, as forementioned, rely on major outbreak datasets with an assumption that the population is fully susceptible.
To overcome such problems, the present study focuses on the meticulous observation of secondary transmissions in Wakayama Prefecture of Japan to estimate R0. By applying the branching process model, which has been widely used to model minor outbreaks with non-negligible stochasticity, the study presents a method to efficiently estimate R0 from very limited data on minor outbreaks. The branching process is particularly useful in quantifying the probability of extinction, a property that is supported by quantifying the offspring distribution and final size, i.e., the cumulative incidence of an outbreak. For a realistic representation of the offspring distribution of directly transmitted infectious diseases, the distribution is frequently assumed to follow a negative binomial distribution with two parameters, R0 and the dispersion parameter k [2,3,4,5,6]. The distribution is highly dispersed for k<1, and a very small value of k implies the presence of a super-spreading event [2]. Geometric and Poisson distributions are special cases of the negative binomial distribution when k→∞ and k=1, respectively.
The branching process model has already been employed to model COVID-19, especially in the early stages of the pandemic [6,7,8,9,10]. Published studies clearly indicate the presence of "over-dispersed" secondary transmission, where k is estimated to range from 0.1–0.3 for the wild type of the virus [9,11,12,13]. Preliminary research on the Delta variant has estimated the dispersion parameter to be k=0.23 (95% confidence interval [CI]: 0.18–0.30) [14], which is broadly consistent with that of the wild type, but published evidence remains scarce.
Wakayama Prefecture of Japan is located 50 km south of Osaka, which is the third-largest prefecture in Japan by population. This prefecture continuously experienced epidemic "waves" of COVID-19, just as other prefectures in Japan did; a "wave" is conventionally recognized as a period of the epidemic with upward and downward trends with substantial and sustaining changes [15,16]. The present study focuses on the first and fifth waves caused, respectively, by the wild type and the Delta variant. Each wave is generally recognized as an epidemic around February to May 2020 [17,18] and July to October 2021, respectively. The COVID-19 epidemic was controlled early in Japan, involving 16,741 confirmed cases and 898 deaths until the end of May 2020; the indices are far fewer than in other industrialized countries that experienced population-level epidemics. Because of the low-impact setting, a thorough contact tracing practice, including retrospective (backward) tracing of contacts involving earlier generations, was possible and was continued over time. The practice yielded an empirically observed offspring distribution and the final size of minor outbreaks.
The objective of the present study is to interpret the empirically collected epidemic data in a low-impact setting by jointly estimating (ⅰ) the relative transmissibility of the Delta variant compared with the wild type and (ⅱ) the relative transmissibility among vaccinated individuals compared with unvaccinated individuals. Contrary to common methods for estimating R0 that rely on large datasets from major outbreaks in a fully susceptible population, our study presents a method to efficiently estimate R0 from very limited data on minor outbreaks. This exercise estimates the basic reproduction number of the Delta variant.
We used two datasets: (a) the epidemiological tracing results of secondary transmission during the first wave in 2020, caused by the wild type, and (b) the number of cases that produced at least one secondary transmission during the fifth wave in 2021, caused by the Delta variant. Other waves (the second, third, and fourth waves) were excluded from our scope since the focus of the present study was to estimate the basic reproduction number of the Delta variant, for which evidence is yet limited compared to other variants.
The observations were made in Wakayama Prefecture, which has a population of ∼917,000. Despite the proximity to the metropolis of Osaka, the first wave within the prefecture was contained at a relatively low level, i.e., only 64 cumulative cases and 3 cumulative deaths were observed from the emergence of COVID-19 until June 30, 2020, compared with 1833 cases and 86 deaths in Osaka in the same period. In Wakayama, reverse transcription-polymerase chain reaction (RT-PCR) testing was conducted intensively, and cluster interventions were handled through contact tracing (i.e., containment effort). The vaccination program in Japan started in the early part of 2021, after the end of the third wave in February 2021. Initially, health care workers were prioritized (starting on February 17), and then the elderly population (over 65 years old) began to be vaccinated starting from April 12. At the peak of the fifth wave, caused by the Delta variant in Japan (August 26, 2021), 41.63% of the entire population had received two doses of vaccine [19]. More than 99% of vaccines were mRNA vaccines, either BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna). Even during the fifth wave, cluster interventions were continued in parallel to vaccination. All cases were confirmed either via RT-PCR testing or antigen testing (including both a qualitative test based on immunochromatogaphy and a quantitative test based on the chemiluminescence enzyme immunoassay (CLEIA) method), and if positive, they were consistently notified to the government health authority (Ministry of Health, Labour and Welfare) in accordance with the Infectious Disease Law.
The first dataset from the first wave covered 25 clusters of COVID-19 infection, and each record included the total number of cases that stemmed from a single primary case. Since each cluster was from a minor outbreak contained at a low level, of which most were reported from households, we could assume that the data was not influenced by public health and social measures (PHSMs) and psychological factors. Minor and major outbreaks are types of epidemics in stochastic SIR models that Whittle characterized in 1955 [20]. Minor outbreaks are generally known to have a shorter duration and substantially fewer cases than major outbreaks [21], and hence we temporarily define the threshold of the final size between the minor and major to be 500 cases for convenience of the discussion. We emphasize that the dataset was from small settings where transmission was contained within each cluster and did not lead to major outbreaks where transmission is prevalent in wide community settings. Considering that the overall infections at the population level also contained at a low level and that the vaccination programs did not exist during the first wave, we can interpret our estimates as the approximation the basic reproduction number, capturing the intrinsic transmission dynamics in a completely susceptible population.
The second dataset from the fifth wave contained the respective numbers of cases that did and did not produce secondary transmission. We assumed that we could ignore the effects of PHSMs since no such kinds of policies were implemented in the region during the period. Furthermore, since the contact tracing practices were continued in the same manner as in the first wave, our estimates can be interpreted as the basic reproduction number for the Delta variant, just as for the wild type. The data were categorized into two groups by vaccination status of the primary case: the "all" group included all cases, regardless of vaccination (i.e., either 0, 1, or 2 doses), whereas the "2 doses" group included cases of individuals who had received two vaccine doses. We obtained values for the "0 or 1 dose" group by subtracting the "2 doses" group from the "all" group. The proportions of those who produced secondary transmissions for each group are shown in Figure 1.
The goal of this study was to estimate R0 and k from limited observations of transmission in the first and fifth waves, where the wild type and Delta variant were respectively dominant. We estimated four parameters, i.e., R0 and k for the wild type, the relative transmissibility of the Delta variant to the wild type (γdelta), and the relative transmissibility among fully vaccinated individuals (post 2 doses of vaccination) compared with unvaccinated individuals (γvac). We used a negative binomial branching process model and estimated the parameters using maximum-likelihood estimation (MLE). The 95% CI for the estimated parameters was obtained from a parametric bootstrapping procedure.
With the assumption of R0>1, because the virus caused a global pandemic, we modelled the final size distribution Z using the Galton–Watson (GW) process that involves a negative binomially distributed offspring distribution. Using the probability generating function (p.g.f.) for Z,
GZ(s)=s(1+R0(1−GZ(s))k)−k | (2.1) |
the probability of the final size being z is expressed as follows:
Pr(Z=z;R0,k)=pz=1z!dzdszGZ(s)|s=0 | (2.2) |
Specifically for z=1 and z≥2, the probabilities of the final size being z are the following [5,22].
{p1=1(1+R0k)kpz=Πz−2j=0(jk+z)z!(kR0+k)kz(R0kR0+k)z−1 | (2.3) |
Because the dataset consists of a series of minor outbreaks, we conditioned the final size distribution on extinction. Thus, under the assumption that the offspring distribution follows a negative binomial distribution with dispersion parameter k, the probability of the final size being z was normalized by the probability of extinction π [5].
Pr(Z=z;minor outbreak)=p′z=1πpz | (2.4) |
π=1(1+R0(1−π)k)k | (2.5) |
The likelihood function for estimating the parameters R0 and k for the wild type, given j complete observations each with a final size of zi, is expressed as follows:
L1(R0,k;zi)=j∏i=1p′z1(1−p′1)=j∏i=1pziπ11−(1π(1+R0k)k)=j∏i=1pzi(1+R0k)kπ(1+R0k)k−1 | (2.6) |
We excluded all observations of z=1, which are sporadic and terminal cases, to adjust for the under-ascertainment of such cases, i.e., compared with the presence of secondary transmission, sporadic primary cases may be far harder to ascertain, especially during the first wave [5,6]. We estimated k indirectly via its reciprocal α=1k, as numerous studies on the estimation of negative binomial parameters have shown that this is better than using k. The sampling distribution for α tends to be more symmetric than that for k, which ensures a faster approach to asymptotic normality [2,3].
Given 14 data points of final size z from the first dataset, from which all observations of z=1 were excluded, we estimated parameters R0 and k. Using the Nelder-Mead method with intial values R0=1.5 and k=0.15, we obtained parameter estimates that maximizes the likelihood function (Eq (2.6)). The optimization was conducted using the R function "optim".
We conducted parametric bootstrapping to obtain the 95% CI of R0 and k. Firstly, we derived the covariance matrix from the Hessian matrix that was returned as part of the optimization result in "optim" function. Using the covariance matrix, we generated 3000 pairs of multivariate normal distributions for R0 and k and calculated the 95% CI with the bootstrap percentile method.
We let the reproduction numbers of the Delta variant in the "0 or 1 dose" group and the "2 doses" group to be:
{R0delta=γdelta⋅R0,R0delta_vac=γvac⋅γdelta⋅R0. | (2.7) |
Here, γdelta expresses the relative transmissibility of the Delta variant compared with that of the wild type, and γvac represents the reduced transmissibility among fully vaccinated individuals compared with unvaccinated individuals. R0 is the basic reproduction number of the wild type. The vaccine effectiveness (VE), in terms of preventing secondary transmission, can be calculated as 100(1−γvac)%. We note that γdelta and γvac are coefficients that represent relative changes in the number of secondary transmissions produced but not the risk of being infected.
Under the assumption that the offspring distribution Y follows a negative binomial distribution, the p.g.f. for having y offspring is as follows.:
GY(s)=(1+R0i(1−s)k)−k | (2.8) |
Using such p.g.f., the probability of having no offspring (y=0) [22] is derived as:
Pr(Y=0)=py=GY(0)=1(1+R0ik)k | (2.9) |
where R0i represents R0delta or R0delta_vac for i=1 and 2, respectively.
The likelihood function for estimating γdelta and γvac is as follows.:
L2(γdelta,γvac;R0,k,ni,mi)=2∏i=1(nimi)pymii(1−pyi)ni−mi+1=2∏i=1(nimi)(1(1+R0ik)k)mi(1−1(1+R0ik)k)ni−mi+1 | (2.10) |
Here, i represents different groups based on vaccine status, where i=1 represents the group with 0 or 1 vaccine doses, and i=2 represents fully vaccinated individuals. ni refers to the total number of people in the category, and mi refers to number of those who had no offspring (y=0). For i=1 in the 0 or 1 dose vaccination group, n1 and m1 had values of 177 and 138, respectively. For i=2 in the fully vaccinated group, n2 and m2 were 726 and 344, respectively.
Given the secondary transmission dataset from the fifth wave and 3000 bootstrap pairs of pre-estimated R0 and k, we estimated parameters γdelta and γvac that maximizes the likelihood function. Using the Nelder-Mead method with intial parameter values γdelta=3 and γvac=0.2, we obtained 3000 pairs of parameter estimates that maximizes the likelihood function. The optimization was conducted using the R function "optim". By the repeating parametric bootstrap for each pairs in the same manner as R0 and k, we obtained 95% CIs for γdelta and γvac.
We assumed that the dispersion parameter k is consistent across SARS-CoV-2. Thus, we conducted a sensitivity analysis of the estimated reproduction number for the Delta variant with different values of the dispersion parameter k. We repeated the estimation for γdelta and γvac using different values of k, ranging between 0.05 and 1, which were minimum and maximum values found either as estimates or the bounds of the CI in prior research [6,7,10,11,12,23,24,25,26,27]. Although there is not yet much evidence for the dispersion parameter of the Delta variant, preliminary research estimates k=0.23 (95% CI: 0.18–0.30) [14], which is within the range of the dispersion parameter for the wild type.
Reproduction numbers of the Delta variant in populations with different vaccination statues were calculated by substituting estimated γdelta and γvac into Eq (2.7). 95% CIs for reproduction numbers were also calculated with the bootstrap percentile method.
All of the analysis in the present study was conducted using R, version 3.6.3 [28].
The present study examined publicly available data that do not contain any personally identifiable information. As such, ethical approval was not required for the present study.
For the wild type of COVID-19, R0 was estimated to be 3.78 (95% CI: 3.72–3.83). This value is higher than suggested by previous research, with meta-analysis and a systematic review concluding that R0 lies in the range from 2–3 [29,30]. The value of k for the wild type was estimated to be 0.236 (95% CI: 0.233–0.240), which is broadly consistent with prior findings [6,8,9,10,12,13,26]. The final size distribution given by the estimated R0 and k is shown in Figure 2, which compares observed data (line) and the fitted model (bars). While the model captures the overall trend of frequency, the frequencies for z=2 and z=3 are underestimated. The fit may be biased by a cluster observed at z=15.
Using the estimated parameters of the wild type, we then estimated the relative transmissibility of the Delta variant and the relative transmissibility among fully vaccinated individuals. The relative transmissibility of the Delta variant to the wild type, γdelta, was estimated to be 1.42 (95% CI: 0.94–1.90). The relative effect on transmissibility from two-dose vaccination, γvac, was estimated to be 0.09 (95% CI: 0.03–0.14). This indicates that VE for preventing secondary transmission among a fully vaccinated population, compared with unvaccinated individuals, was 91% (95% CI: 85%–97%).
By substituting the estimated parameters into Eq (2.7), the basic reproduction number of the Delta variant, R0delta, was calculated as 5.37 (95% CI: 3.55–7.21). This value is consistent with prior research findings, which indicate a mean value of 5.08 [31]. The reproduction number of the Delta variant among fully vaccinated individuals, R0delta_vac, was calculated to be 0.44 (95% CI: 0.20–0.69). This result highlights that the reproduction number in the fully vaccinated population was well below 1.
The offspring distribution of the Delta variant was calculated using the mean of the estimated reproduction number for both the 0 or 1 dose population and the 2 doses population (Figure 3). The dispersion parameter k was assumed to be identical to the estimated value for the wild type (k=0.236). The left panel shows the result for the population with vaccination status of either 0 or 1 dose, while the right panel shows the result for 2 doses. The dotted horizontal line identifies the observed frequency of those who did not cause a secondary infection (y=0). For the 2 doses population, the estimated frequency from the model matches that of the observed data.
The results of sensitivity analysis with various values of the dispersion parameter k are shown in Figure 4. Dotted vertical lines indicate the value of the dispersion parameter (k=0.23) estimated from the data for the wild type. At k=0.05, the Delta variant is estimated to have an R0 value of 2878.75 (95% CI 1248.96–4458.64), while at k=1.0, R0 is 1.11 (95% CI 0.95–1.28) (Panel C). As shown in Panel B, the relative transmissibility among fully vaccinated individuals is reduced at smaller k values, meaning that there is a greater reduction in the number of secondary transmissions. The reproduction number in fully vaccinated individuals was estimated to be less than 1 for all k values greater than 0.15.
Using meticulously observed contact tracing data from Wakayama prefecture in early 2020 and mid-2021, we estimated the basic reproduction number R0 and the dispersion parameter k of the wild-type COVID-19, as well as the relative transmissibility of the Delta variant and relative transmissibility among fully vaccinated individuals. For the wild type, R0 was estimated to be 3.78, and k was estimated to be 0.24. For the Delta variant, we estimated that R0 is 5.37, which is in line with preliminary findings reporting a mean of 5.08 [31]. Our estimates also indicated that the number of secondary transmissions was reduced by 91% among fully vaccinated individuals. To the best of our knowledge, no previous research has quantified the R0 value of the COVID-19 Delta variant from minor outbreak data while accounting for the relative transmissibility among fully vaccinated individuals.
The present study highlights that the basic reproduction numbers of variants can efficiently be estimated by applying the branching process model to the distribution of minor outbreak data. We emphasize that our method provides "relative transmissibility" of emerging variants on the basic reproduction number, not the effective reproduction number. This provides the basic reproduction numbers of new variants that work as fundamental indices for controlling pandemics (i.e., in planning strategies of vaccination programs). Our methods can be applied if epidemiological surveys are being conducted at a constant level, and the relative susceptibility within the population remains at a comparable level. Moreover, we emphasize that the data from minor outbreaks, which are a type of epidemic that has a small number of cases, can provide further insightful epidemiological estimates, including the dispersion parameter and VE in terms of preventing transmission. While the estimated R0 of the wild type was higher than the commonly agreed value, it was within the upper range of published CIs [29,30]. Furthermore, we have proved that VE in terms of preventing secondary transmission can also be estimated from limited observed data. Finally, the 95% CI for the estimated R0 of the Delta variant overlaps with values reported in existing studies [31,32].
The strength of the present study lies in the successful estimation of the basic reproduction number R0 of the Delta variant from minimal observed data of minor outbreaks. Understanding R0 is essential in planning effective strategies to contain the spread of the virus, particularly when it is known to be growing with the emergence of new variants. Furthermore, estimations regarding the Delta variant were made possible by assuming that the dispersion parameter is equivalent to that of the wild type, which we estimated from another dataset collected in the same geographic region. We could have separately estimated the dispersion parameter if either the final size or offspring distribution had also been observed for the Delta variant.
Our results imply that contact tracing is a critical factor that can enhance future data collection during the pandemic. Our findings prove that contact tracing data contribute to estimations of transmissibility and VE. To further understand the nature of the virus and its mechanisms of transmission, surveillance should be customized to include information as follows: vaccination status, number of secondary transmissions (not only whether they did or did not cause secondary transmission), detailed demographic and epidemiological attributes (i.e., sex and age group for each reported case). This information allows a more explicit and detailed analysis of the transmission dynamics specific to particular population groups and settings.
We must address some limitations of our study. First, the data on secondary transmission were identified through epidemiological investigation, which relied on the local capacity of contact tracing and patient cooperation in the tracing practice. The tracing method means that there is always the possibility of recall bias, which may lead to the presence of unascertained cases. However, because backward tracing was combined with forward tracing in Japan, it is likely that most secondary transmission, including asymptomatic cases, was captured. More active testing strategies, including daily PCR testing, may capture more comprehensive transmission dynamics. Second, the sample size of the final size distribution was limited to only 25 clusters. While it is still very rare for data to be observed, the estimates for R0 and k could have been more consistent with existing research if more reports were available. A serological survey could have been conducted so that the actual final size could be determined without the possibility of any biases. Third, the fifth wave dataset lacked a detailed offspring distribution, but it instead included the respective frequencies of those who did or did not cause secondary transmissions. If the full distribution of secondary transmission per person was observed (e.g., y=1,2,3,…), R0 and k for the Delta variant could have been separately estimated with greater precision. While modeling from a limited dataset is still possible under certain assumptions, a detailed offspring distribution is essential in understanding the full nature of the transmission dynamics of infectious diseases. Finally, the waning of vaccine-induced immunity was ignored. Because the fifth wave occurred amid the vaccination program, we believe it was not essential to meticulously measure the time since vaccination at an individual level.
In conclusion, the present study has demonstrated a method to estimate the basic reproduction number of a new variant, denoted by the relative transmissibility from an existing type of virus, through the application of branching process models on very limited data. We emphasize that our method does not rely on exponential growth rate and generation time distribution models that require major outbreak datasets from fully susceptible populations. Using the final size and offspring distribution of minor outbreaks aggregated based on intensive contact tracing, we have estimated that the Delta variant is 1.42 times as transmissive as the wild type of COVID-19, which results in R0 of 5.37. The VE in the reduction in the number of secondary transmissions was estimated to be 91% among fully vaccinated individuals compared with unvaccinated individuals.
The study has also presented the importance of collecting pieces of information on minor outbreaks, where transmissions are contained in small settings without spreading to a wide range of communities in the population. We emphasize that offspring and final size distributions accumulated based on intensive contact tracing practices or serological surveys can significantly contribute to determining the fundamental indices for understanding and controlling outbreaks.
H. N. received funding from Health and Labour Sciences Research Grants (20CA2024, 20HA2007, 21HB1002 and 21HA2016), the Japan Agency for Medical Research and Development (JP20fk0108140, JP20fk0108535, and JP21fk0108612), the Japan Society for the Promotion of Science (JSPS) KAKENHI (21H03198), the Environment Research and Technology Development Fund (JPMEERF20S11804) of the Environmental Restoration and Conservation Agency of Japan, and the Japan Science and Technology Agency SICORP program (JPMJSC20U3 and JPMJSC2105). We thank local governments, public health centers, and institutes for surveillance, laboratory testing, epidemiological investigations, and data collection. We thank Stuart Jenkinson, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.
The authors declare there is no conflict of interest.
[1] |
T. Singhal, A review of coronavirus disease-2019 (COVID-19), Indian J. Pediatr., 87 (2020), 281–286. doi: 10.1007/s12098-020-03263-6
![]() |
[2] |
N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395 (2020), 507–513. doi: 10.1016/S0140-6736(20)30211-7
![]() |
[3] |
I. Valverde, Y. Singh, J. Sanchez-de Toledo, P. Theocharis, A. Chikermane, S. Di Filippo, et al., Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe, Circulation, 143 (2021), 21–32. doi: 10.1161/CIRCULATIONAHA.120.050065
![]() |
[4] | J. Riou, C. L. Althaus, Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020, Eurosurveillance, 25 (2020), 2000058. |
[5] | L. Yuan, N. Zhi, C. Yu, G. Ming, L. Yingle, G. N. Kumar, et al., Aerodynamic characteristics and RNA concentration of SARS-CoV-2 aerosol in Wuhan hospitals during COVID-19 outbreak, BioRxiv, 2020. |
[6] |
N. Van Doremalen, T. Bushmaker, D. H. Morris, M. G. Holbrook, A. Gamble, B. N. Williamson, et al., Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N. Engl. J Med., 382 (2020), 1564–1567. doi: 10.1056/NEJMc2004973
![]() |
[7] |
J. Hellewell, S. Abbott, A. Gimma, N. I. Bosse, C. I. Jarvis, T. W. Russell, et al., Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts, Lancet Global Health, 8 (2020), e488–e496. doi: 10.1016/S2214-109X(20)30074-7
![]() |
[8] | M. Lotfi, M. R. Hamblin, N. Rezaei, COVID-19: transmission, prevention, and potential therapeutic opportunities, Clin. Chim. Acta, 2020. |
[9] |
R. P. Singh, M. Javaid, A. Haleem, R. Suman, Internet of things (IoT) applications to fight against COVID-19 pandemic, Diabetes Metab. Syndr. Clin. Res. Rev., 14 (2020), 521–524. doi: 10.1016/j.dsx.2020.04.041
![]() |
[10] | M. Hasan, A. Rahman, M. J. Islam, Distb-cvs: a distributed secure blockchain based online certificate verification system from bangladesh perspective, in 2020 2nd International Conference on Advanced Information and Communication Technology (ICAICT), (2020), 460–465. |
[11] | D. Abid Haleem, M. Javaid, I. H. Khan, B. Tech, Internet of things (IoT) applications in orthopaedics, 2019. |
[12] | R. Jiloha, COVID-19 and mental health, Epidemiol. Int. (E-ISSN: 2455-7048), 5 (2020), 7–9. |
[13] |
A. Haleem, M. Javaid, R. Vaishya, S. Deshmukh, Areas of academic research with the impact of COVID-19, Am. J. Emerg. Med., 38 (2020), 1524–1526. doi: 10.1016/j.ajem.2020.04.022
![]() |
[14] | K. M. S. Azad, N. Hossain, M. J. Islam, A. Rahman, S. Kabir, Preventive determination and avoidance of ddos attack with sdn over the iot networks. in International Conference on Automation, Control and Mechatronics for Industry 4.0 (ACMI 2021), IEEE, 2021. |
[15] |
A. Rahman, M. K. Nasir, Z. Rahman, A. Mosavi, S. Shahab, B. Minaei-Bidgoli, Distblockbuilding: a distributed blockchain-based sdn-iot network for smart building management, IEEE Access, 8 (2020), 140008–140018. doi: 10.1109/ACCESS.2020.3012435
![]() |
[16] | M. Mohammed, H. Syamsudin, S. Al-Zubaidi, R. R. AKS, E. Yusuf, Novel COVID-19 detection and diagnosis system using iot based smart helmet, Int. J. Psychosoc. Rehabil., 24 (2020), 2296–2303. |
[17] | D. Darma, Z. Ilmi, S. Darma, Y. Syaharuddin, COVID-19 and its impact on education: challenges from industry 4.0, 2020. |
[18] | Z. Ilmi, D. C. Darma, M. Azis, Independence in learning, education management, and industry 4.0: habitat indonesia during COVID-19, J. Anthropol. Sport Phys. Educ., 4 (2020), 63–66. |
[19] |
K. Kumar, N. Kumar, R. Shah, Role of IoT to avoid spreading of COVID-19, Int. J. Intell. Networks, 1 (2020), 32–35. doi: 10.1016/j.ijin.2020.05.002
![]() |
[20] |
K. Farsalinos, K. Poulas, D. Kouretas, A. Vantarakis, M. Leotsinidis, D. Kouvelas, et al., Improved strategies to counter the COVID-19 pandemic: lockdowns vs. primary and community healthcare, Toxicol. Rep., 8 (2021), 1–9. doi: 10.1016/j.toxrep.2020.12.001
![]() |
[21] | Centers for Disease Control and Prevention, Coronavirus Disease 2019: COVID-19, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/index.html. |
[22] |
L. H. Nguyen, D. A. Drew, M. S. Graham, A. D. Joshi, C. G. Guo, W. Ma, et al., Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study, Lancet Public Health, 5 (2020), e475–e483. doi: 10.1016/S2468-2667(20)30164-X
![]() |
[23] | A. Haleem, M. Javaid, Medical 4.0 and its role in healthcare during COVID-19 pandemic: a review, J. Ind. Integr. Manage., 5 (2020). |
[24] |
A. Celesti, M. Fazio, F. Galán Márquez, A. Glikson, H. Mauwa, A. Bagula, How to develop IoT cloud e-health systems based on fiware: a lesson learnt, J. Sensor Actuator Networks, 8 (2019), 7. doi: 10.3390/jsan8010007
![]() |
[25] | S. Debdas, C. K. Panigrahi, P. Kundu, S. Kundu, R. Jha, IoT application in interconnected hospitals, Mach. Learn. Healthcare Appl., (2021), 227. |
[26] |
A. Albahri, J. K. Alwan, Z. K. Taha, S. F. Ismail, R. A. Hamid, A. Zaidan, et al., IoT-based telemedicine for disease prevention and health promotion: state-of-the-art, J. Network Comput. Appl., 173 (2021), 102873. doi: 10.1016/j.jnca.2020.102873
![]() |
[27] | M. Shahroz, F. Ahmad, M. S. Younis, N. Ahmad, M. N. K. Boulos, R. Vinuesa, et al., COVID-19 digital contact tracing applications and techniques: a review post initial deployments, preprint, arXiv: 2103.01766. |
[28] | S. Mohapatra, S. Mohanty, S. Mohanty, Smart healthcare: an approach for ubiquitous healthcare management using IoT, in Big Data Analytics for Intelligent Healthcare Management, Elsevier, (2019), 175–196. |
[29] |
A. Rahman, M. J. Islam, Z. Rahman, M. M. Reza, A. Anwar, M. P. Mahmud, et al., Distb-condo: distributed blockchain-based IoT-sdn model for smart condominium, IEEE Access, 8 (2020), 209 594–209 609. doi: 10.1109/ACCESS.2020.3039113
![]() |
[30] |
K. N. Swaroop, K. Chandu, R. Gorrepotu, S. Deb, A health monitoring system for vital signs using IoT, Internet Things, 5 (2019), 116–129. doi: 10.1016/j.iot.2019.01.004
![]() |
[31] | A. Zamanifar, Remote patient monitoring: health status detection and prediction in IoT-based health care, in IoT in Healthcare and Ambient Assisted Living, Springer, (2021), 89–102. |
[32] | A. Rahman, M. J. Islam, M. Saikat Islam Khan, S. Kabir, A. I. Pritom, M. Razaul Karim, Block-sdotcloud: enhancing security of cloud storage through blockchain-based sdn in IoT network, in 2020 2nd International Conference on Sustainable Technologies for Industry 4.0 (STI), (2020), 1–6. |
[33] |
M. R. Valanarasu, Smart and secure IoT and AI integration framework for hospital environment, J. ISMAC, 1 (2019), 172–179. doi: 10.36548/jismac.2019.3.004
![]() |
[34] |
A. Alamri, Ontology middleware for integration of IoT healthcare information systems in ehr systems, Computers, 7 (2018), 51. doi: 10.3390/computers7040051
![]() |
[35] |
T. Wu, F. Wu, C. Qiu, J. M. Redouté, M. R. Yuce, A rigid-flex wearable health monitoring sensor patch for IoT-connected healthcare applications, IEEE Internet Things J., 7 (2020), 6932–6945. doi: 10.1109/JIOT.2020.2977164
![]() |
[36] |
D. Zhang, X. Xia, Y. Yang, P. Yang, C. Xie, M. Cui, et al., A novel word similarity measure method for IoT-enabled healthcare applications, Future Gener. Comput. Syst., 114 (2021), 209–218. doi: 10.1016/j.future.2020.07.053
![]() |
[37] | S. Selvaraj, S. Sundaravaradhan, Challenges and opportunities in IoT healthcare systems: a systematic review, SN Appl. Sci., 2 (2020), 1–8. |
[38] |
N. Gupta, S. Gupta, M. Khosravy, N. Dey, N. Joshi, R. G. Crespo, et al., Economic iot strategy: the future technology for health monitoring and diagnostic of agriculture vehicles, J. Int. Manuf., 32 (2021), 1117–1128. doi: 10.1007/s10845-020-01610-0
![]() |
[39] | P. P. Ray, B. Chowhan, N. Kumar, A. Almogren, Biothr: electronic health record servicing scheme in IoT-blockchain ecosystem, IEEE Internet Things J., 2021. |
[40] |
M. Javaid, I. H. Khan, Internet of things (IoT) enabled healthcare helps to take the challenges of COVID-19 pandemic, J. Oral Biol. Craniofacial Res., 11 (2021), 209–214. doi: 10.1016/j.jobcr.2021.01.015
![]() |
[41] |
I. de Morais Barroca Filho, G. Aquino, R. S. Malaquias, G. Girão, S. R. M. Melo, An IoT-based healthcare platform for patients in ICU beds during the COVID-19 outbreak, IEEE Access, 9 (2021), 27262–27277. doi: 10.1109/ACCESS.2021.3058448
![]() |
[42] |
A. Islam, S.Y. Shin, A blockchain-based secure healthcare scheme with the assistance of unmanned aerial vehicle in Internet of Things, Comput. Electr. Eng., 84 (2020), 106627. doi: 10.1016/j.compeleceng.2020.106627
![]() |
[43] | A. Islam, T. Rahim, M. D. Masuduzzaman, S. Y. Shin, A blockchain-based artificial intelligence-empowered contagious pandemic situation supervision scheme using internet of drone things. IEEE Wireless Commun., 2021. |
[44] |
M. Elhoseny, G. Ramírez-González, O. M. Abu-Elnasr, S. A. Shawkat, N. Arunkumar, A. Farouk, Secure medical data transmission model for IoT-based healthcare systems, IEEE Access, 6 (2018), 20 596–20 608. doi: 10.1109/ACCESS.2018.2817615
![]() |
[45] | S. Pirbhulal, N. Pombo, V. Felizardo, N. Garcia, A. H. Sodhro, S. C. Mukhopadhyay, Towards machine learning enabled security framework for IoT-based healthcare, in 2019 13th International Conference on Sensing Technology (ICST), IEEE, (2019), 1–6. |
[46] | S. Saha, A. K. Sutrala, A. K. Das, N. Kumar, J. J. Rodrigues, On the design of blockchain-based access control protocol for IoT-enabled healthcare applications, in ICC 2020-2020 IEEE International Conference on Communications (ICC), IEEE, 2020, 1–6. |
[47] |
S. S. Sahoo, S. Mohanty, B. Majhi, A secure three factor based authentication scheme for health care systems using IoT enabled devices, J. Ambient Intell. Humanized Comput., 12 (2021), 1419–1434. doi: 10.1007/s12652-020-02213-6
![]() |
[48] |
A. Hussain, T. Ali, F. Althobiani, U. Draz, M. Irfan, S. Yasin, et al., Security framework for IoT based real-time health applications, Electronics, 10 (2021), 719. doi: 10.3390/electronics10060719
![]() |
[49] | World Health Organization, 2020. Digital technology for COVID-19 response, Available from: https://www.who.int/news/item/03-04-2020-digital-technology-for-covid-19-response. |
[50] |
A. Gatouillat, Y. Badr, B. Massot, E. Sejdić, Internet of medical things: a review of recent contributions dealing with cyber-physical systems in medicine, IEEE Internet Things J., 5 (2018), 3810–3822. doi: 10.1109/JIOT.2018.2849014
![]() |
[51] | L. Wynants, B. Van Calster, G. S. Collins, R. D. Riley, G. Heinze, E. Schuit, et al., Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal, BMJ, 369 (2020). |
[52] | L. Yuan, W. Yeung, L. Celi, Urban intelligence for pandemic response, JMIR Public Health Surveill., 2020. |
[53] |
V. Chamola, V. Hassija, V. Gupta, M. Guizani, A comprehensive review of the COVID-19 pandemic and the role of IoT, Drones, AI, Blockchain, and 5G in managing its impact, IEEE Access, 8 (2020), 90 225–90 265. doi: 10.1109/ACCESS.2020.2992341
![]() |
[54] | Q. V. Pham, D. C. Nguyen, T. Huynh-The, W. J. Hwang, P. N. Pathirana, Artificial intelligence (AI) and big data for coronavirus (COVID-19) pandemic: a survey on the state-of-the-arts, 2020. |
[55] |
A. A. Ardakani, A. R. Kanafi, U. R. Acharya, N. Khadem, A. Mohammadi, Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: eesults of 10 convolutional neural networks, Comput. Biol. Med., 121 (2020), 103795. doi: 10.1016/j.compbiomed.2020.103795
![]() |
[56] |
M. A. Elaziz, K. M. Hosny, A. Salah, M. M. Darwish, S. Lu, A. T. Sahlol, New machine learning method for image-based diagnosis of COVID-19, Plos One, 15 (2020), e0235187. doi: 10.1371/journal.pone.0235187
![]() |
[57] |
A. Imran, I. Posokhova, H. N. Qureshi, U. Masood, M. S. Riaz, K. Ali, et al., AI4covid-19: AI enabled preliminary diagnosis for COVID-19 from cough samples via an app, Inf. Med. Unlocked, 20 (2020), 100378. doi: 10.1016/j.imu.2020.100378
![]() |
[58] | I. Ahmed, A. Ahmad, G. Jeon, An IoT based deep learning framework for early assessment of COVID-19, IEEE Internet Things J., 2020. |
[59] | Autonomous robot performs COVID-19 nasal swab tests, 2020. Available from: https://www.hospimedica.com/health-it/articles/294783922/autonomous-robot-performs-covid-19-nasal-swab-tests.html. |
[60] | M. Nasajpour, S. Pouriyeh, R. M. Parizi, M. Dorodchi, M. Valero, H. R. Arabnia, Internet of Things for current COVID-19 and future pandemics: an exploratory study, J. Healthcare Inf. Res., (2020), 1–40. |
[61] | Visionstate ships first IoT buttons for rapid response to cleaning alerts, 2020. Available from: https://www.globenewswire.com/news-release/2020/03/23/2004645/0/en/Visionstate-Ships-First-IoT-Buttons-for-Rapid-Response-to-Cleaning-Alerts.html. |
[62] | S. Obeidat, How artificial intelligence is helping fight the COVID-19 pandemic, Entrepreneur Middle East, 2020. |
[63] | M. Schmitt, How to fight COVID-19 with machine learning, 2020. Available from: https://www.datarevenue.com/en-blog/machine-learning-covid-19. |
[64] | E. Strickland, AI can help hospitals triage COVID-19 patients, IEEE Spectrum, 2020. Available from: https://spectrum.ieee.org/the-human-os/artificial-intelligence/medical-ai/ai-can-help-hospitals-triage-covid19-patients. |
[65] | Kinsa is an early warning system to detect and respond to contagious illness, 2020. Available from: https://kinsahealth.com/. |
[66] |
T. Tamura, M. Huang, T. Togawa, Current developments in wearable thermometers, Adv. Biomed. Eng., 7 (2018), 88–99. doi: 10.14326/abe.7.88
![]() |
[67] | P. Vaishnavi, J. Agnishwar, K. Padmanathan, S. Umashankar, T. Preethika, S. Annapoorani, et al., Artificial intelligence and drones to combat COVID-19, Preprints, 2020. |
[68] | Media Centre, Working on pandemic drone to detect corona virus, 2020. Available from: https://www.suasnews.com/2020/03/unisa-working-on-pandemic-drone-to-detect-coronavirus/. |
[69] | M. Mohammed, N. A. Hazairin, S. Al-Zubaidi, S. A. Karim, S. Mustapha, E. Yusuf, Toward a novel design for coronavirus detection and diagnosis system using IoT based drone technology, Int. J. Psychosoc. Rehabil., 24 (2020), 2287–2295. |
[70] | M. Mohammed, N. A. Hazairin, H. Syamsudin, S. Al-Zubaidi, A. Sairah, S. Mustapha, et al., 2019 novel coronavirus disease (COVID-19): detection and diagnosis system using IoT based smart glasses, Int. J. Adv. Sci. Technol., 29 (2020). |
[71] |
G. Quer, J. M. Radin, M. Gadaleta, K. Baca-Motes, L. Ariniello, E. Ramos, et al., Wearable sensor data and self-reported symptoms for COVID-19 detection, Nat. Med., 27 (2021), 73–77. doi: 10.1038/s41591-020-1123-x
![]() |
[72] | Estimote wearables track workers to curb COVID-19 outbreak, 2020. Available from: https://www.slashgear.com/estimote-wearables-track-workers-to-curb-covid-19-outbreak-02615366/. |
[73] | T. Hornyak, What America can learn from China's use of robots and telemedicine to combat the coronavirus, Tech. Drivers, 2020. |
[74] | M. Hollister, AI can help with the COVID-19 crisis-but the right human input is key, in World Economic Forum, 30 (2020). |
[75] | R. K. R. Kummitha, Smart technologies for fighting pandemics: the techno-and human-driven approaches in controlling the virus transmission, Gov. Inf. Q., (2020), 101481. |
[76] | D. DeCaprio, J. Gartner, T. Burgess, K. Garcia, S. Kothari, S. Sayed, et al., Building a COVID-19 vulnerability index, preprint, arXiv: 2003.07347. |
[77] | A. Rahman, M. J. Islam, M. R. Karim, D. Kundu, S. Kabir, An intelligent vaccine distribution process in COVID-19 pandemic through blockchain-sdn framework from bangladesh perspective, in International Conference on Electronics, Communications and Information Technology 2021 (ICECIT 2021), 2021. |
[78] | M. Zastrow, Coronavirus contact-tracing apps: can they slow the spread of COVID-19? Nature, 2020. |
[79] |
Z. Geng, X. Zhang, Z. Fan, X. Lv, Y. Su, H. Chen, Recent progress in optical biosensors based on smartphone platforms, Sensors, 17 (2017), 2449. doi: 10.3390/s17112449
![]() |
[80] | T. Wright, Blockchain app used to track COVID-19 cases in Latin America, Coin Telegraph Future Money, 6 (2020). |
[81] | Ministry of Health, HaMagen 2.0: together we can defeat COVID-19, Available from: https://govextra.gov.il/ministry-of-health/hamagen-app/download-en/. |
[82] | C. Chong, About 1 million people have downloaded tracetogether app, but more need to do so for it to be effective: lawrence wong, Straits Times, 2020. |
[83] | L. Kelion, Coronavirus: moscow rolls out patient-tracking app, 2020. |
[84] | A. Rahman, C. Chakraborty, A. Anwar, M. Karim, M. Islam, D. Kundu, et al., Sdn–IoT empowered intelligent framework for industry 4.0 applications during COVID-19 pandemic, Cluster Comput., (2021), 1–18. |
[85] | Teladochealth, Whole-Person: virtual care for all, Available from: https://www.teladochealth.com/. |
[86] | A. Chakraborty, Assam: telemedicine, video monitoring for COVID-19 home quarantined people in Dhemaji, 2020. |
[87] | D. O'Keeffe, A World First as Drone delivers medication to the Aran Islands, 2019. |
[88] | J. Yang, T. Reuter, Three ways China is using drones to fight coronavirus, in World Economic Forum, 16 (2020). |
[89] | E. Ackerman, Zipline wants to bring medical drone delivery to us to fight COVID-19, IEEE Spectrum N. Y. NY USA, 2020. |
[90] | S. Sahasranamam, How coronavirus sparked a wave of innovation in India, in World Economic Forum, 2020. |
[91] |
M. Javaid, A. Haleem, R. Vaishya, S. Bahl, R. Suman, A. Vaish, Industry 4.0 technologies and their applications in fighting COVID-19 pandemic, Diabetes Metab. Syndr. Clin. Res. Rev., 14 (2020), 419–422. doi: 10.1016/j.dsx.2020.06.065
![]() |
[92] | A. Ghimire, S. Thapa, A. K. Jha, A. Kumar, A. Kumar, S. Adhikari, AI and IoT solutions for tackling COVID-19 pandemic, in 2020 4th International Conference on Electronics, Communication and Aerospace Technology (ICECA), IEEE, (2020), 1083–1092. |
[93] |
L. Bai, D. Yang, X. Wang, L. Tong, X. Zhu, N. Zhong, et al., Chinese experts' consensus on the Internet of things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19), Clin. eHealth, 3 (2020), 7–15. doi: 10.1016/j.ceh.2020.03.001
![]() |
[94] | M. J. Islam, A. Rahman, S. Kabir, M. R. Karim, U. K. Acharjee, M. K. Nasir, et al., Blockchain-sdn based energy-aware and distributed secure architecture for IoTs in smart cities, IEEE Internet Things J., (2021), 1. |
[95] | World Certification Institute, How next-generation information technologies tackled COVID-19 in China, 2020. Available from: https://www.worldcertification.org/how-next-generation-information-technologies-tackled-covid-19-china/. |
[96] | H. H. Elmousalami, A. Darwish, A. E. Hassanien, The truth about 5G and COVID-19: basics, analysis, and opportunities, in Digital Transformation and Emerging Technologies for Fighting COVID-19 Pandemic: Innovative Approaches, (2021), 249–259, . |
[97] | A. Rahman, U. Sara, D. Kundu, S. Islam, M. J. Islam, M. Hasan, et al., Distb-sdoindustry: enhancing security in industry 4.0 services based on distributed blockchain through software defined networking-IoT enabled architecture, Int. J. Adv. Comput. Sci. Appl., 11 (2020). |
[98] | S. Jaafari, A. Alhasani, S. M. Almutairi, E. Alghosn, R. Alfahhad, Certain investigations on IoT system for COVID-19, in 2020 International Conference on Computing and Information Technology (ICCIT-1441), IEEE, (2020), 1–4. |
[99] | R. Stojanović, A. Škraba, B. Lutovac, A headset like wearable device to track COVID-19 symptoms, in 2020 9th Mediterranean Conference on Embedded Computing (MECO), IEEE, (2020), 1–4. |
[100] | Researchers use open-source software to improve COVID-19 screening with AI, 2020. Available from: https://uwaterloo.ca/news/news/researchers-use-open-source-software-improve-covid-19. |
[101] | B. Marr, Robots and drones are now used to fight COVID-19, 2020. |
[102] | Delhi civic body begins thermal screening people on balconies with drones, 2020. Available from: https://www.ndtv.com/delhi-news/coronavirus-delhi-civic-body-using-drones-to-check-temperature-of-people-on-balconies-2209832. |
[103] |
M. Abdel-Basset, V. Chang, N. A. Nabeeh, An intelligent framework using disruptive technologies for COVID-19 analysis, Technol. Forecast. Soc. Change, 163 (2021), 120431. doi: 10.1016/j.techfore.2020.120431
![]() |
[104] | S. Gilgore, GWU hospital tackles COVID-19 with new testing site, telemedicine and outreach on D.C.'s east side, 2020. |
[105] | M. Shah, A. Tosto, Industry voices—how rush university medical center's virtual investments became central to its COVID-19 response, 2020. |
[106] | S. Simmons, R. Carrion, K. Alfson, H. Staples, C. Jinadatha, W. Jarvis, et al., Disinfection effect of pulsed xenon ultraviolet irradiation on SARS-CoV-2 and implications for environmental risk of COVID-19 transmission, medRxiv, 2020. |
[107] | B. Spice, COVID-19 should be wake-up call for robotics research, 2020. |
[108] |
R. Vaishya, M. Javaid, I. H. Khan, A. Haleem, Artificial intelligence (AI) applications for COVID-19 pandemic, Diabetes Metab. Syndr. Clin. Res. Rev., 14 (2020), 337–339. doi: 10.1016/j.dsx.2020.04.012
![]() |
[109] | B. G. Ahn, Y. H. Noh, D. U. Jeong, Smart chair based on multi heart rate detection system, in 2015 IEEE SENSORS, IEEE, (2015), 1–4. |
[110] | I. Chiuchisan, H. N. Costin, O. Geman, Adopting the Internet of things technologies in health care systems, in 2014 International Conference and Exposition on Electrical and Power Engineering (EPE), IEEE, (2014), 532–535. |
[111] |
P. K. Sahoo, S. K. Mohapatra, S. L. Wu, Analyzing healthcare big data with prediction for future health condition, IEEE Access, 4 (2016), 9786–9799. doi: 10.1109/ACCESS.2016.2647619
![]() |
[112] | G. Sharma, S. Kalra, A lightweight user authentication scheme for cloud-IoT based healthcare services, Iran. J. Sci. Technol. Trans. Electr. Eng., 43 (2019), 619–636. |
[113] | F. Shi, J. Wang, J. Shi, Z. Wu, Q. Wang, Z. Tang, et al., Review of artificial intelligence techniques in imaging data acquisition, segmentation and diagnosis for COVID-19, IEEE Rev. Biomed. Eng., 2020. |
[114] |
L. Wang, Z. Q. Lin, A. Wong, COVID-net: atailored deep convolutional neural network design for detection of COVID-19 cases from chest x-ray images, Sci. Rep., 10 (2020), 1–12. doi: 10.1038/s41598-019-56847-4
![]() |
[115] | M. Farooq, A. Hafeez, COVID-resnet: A deep learning framework for screening of COVID-19 from radiographs, preprint, arXiv: 2003.14395. |
[116] |
A. Roy, F. H. Kumbhar, H. S. Dhillon, N. Saxena, S. Y. Shin, S. Singh, Efficient monitoring and contact tracing for COVID-19: a smart iot-based framework, IEEE Internet Things Mag., 3 (2020), 17–23. doi: 10.1109/IOTM.0001.2000145
![]() |
[117] |
L. Wang, Microwave sensors for breast cancer detection, Sensors, 18 (2018), 655. doi: 10.3390/s18020655
![]() |
[118] | T. C. Chiang, Y. S. Huang, R. T. Chen, C. S. Huang, R. F. Chang, Tumor detection in automated breast ultrasound using 3-d cnn and prioritized candidate aggregation, IEEE Trans. Med. Imaging, 38 (2018), 240–249. |
[119] |
Y. Lei, X. He, J. Yao, T. Wang, L. Wang, W. Li, et al., Breast tumor segmentation in 3d automatic breast ultrasound using mask scoring r-cnn, Med. Phys., 48 (2021), 204–214. doi: 10.1002/mp.14569
![]() |
[120] |
M. Veta, Y. J. Heng, N. Stathonikos, B. E. Bejnordi, F. Beca, T. Wollmann, et al., Predicting breast tumor proliferation from whole-slide images: the tupac16 challenge, Med. Image Anal., 54 (2019), 111–121. doi: 10.1016/j.media.2019.02.012
![]() |
[121] | G. Pradhan, R. Pradhan, B. Khandelwal, A study on various machine learning algorithms used for prediction of diabetes mellitus, in Soft Computing Techniques and Applications, Springer, (2021), 553–561. |
[122] | A. Shanthini, G. Manogaran, G. Vadivu, K. Kottilingam, P. Nithyakani, C. Fancy, Threshold segmentation based multi-layer analysis for detecting diabetic retinopathy using convolution neural network, J. Ambient Intell. Human. Comput., (2021), 1–15. |
[123] |
V. Bavkar, A. Shinde, Machine learning algorithms for diabetes prediction and neural network method for blood glucose measurement, Indian J. Sci. Technol., 14 (2021), 869–880. doi: 10.17485/IJST/v14i10.2187
![]() |
[124] |
E. Hussain, M. Hasan, M. A. Rahman, I. Lee, T. Tamanna, M. Z. Parvez, Corodet: a deep learning based classification for COVID-19 detection using chest x-ray images, Chaos Solitons Fractals, 142 (2021), 110495. doi: 10.1016/j.chaos.2020.110495
![]() |
[125] | P. R. Bassi, R. Attux, A deep convolutional neural network for COVID-19 detection using chest x-rays, Res. Biomed. Eng., (2021), 1–10. |
[126] |
A. M. Ismael, A. Şengür, Deep learning approaches for COVID-19 detection based on chest x-ray images, Expert Syst. Appl., 164 (2021), 114054. doi: 10.1016/j.eswa.2020.114054
![]() |
[127] |
A. Tahamtan, A. Ardebili, Real-time rt-pcr in COVID-19 detection: issues affecting the results, Expert Rev. Mol. Diagn., 20 (2020), 453–454. doi: 10.1080/14737159.2020.1757437
![]() |
[128] | B. Ghoshal, A. Tucker, Estimating uncertainty and interpretability in deep learning for coronavirus (COVID-19) detection, preprint, arXiv: 2003.10769. |
[129] | A. Mangal, S. Kalia, H. Rajgopal, K. Rangarajan, V. Namboodiri, S. Banerjee, et al., Covidaid: COVID-19 detection using chest x-ray, preprint, arXiv: 2004.09803. |
[130] |
S. Vaid, R. Kalantar, M. Bhandari, Deep learning COVID-19 detection bias: accuracy through artificial intelligence, Int. Orthop., 44 (2020), 1539–1542. doi: 10.1007/s00264-020-04609-7
![]() |
[131] |
A. Waheed, M. Goyal, D. Gupta, A. Khanna, F. Al-Turjman, P. R. Pinheiro, Covidgan: data augmentation using auxiliary classifier gan for improved COVID-19 detection, IEEE Access, 8 (2020), 91 916–91 923. doi: 10.1109/ACCESS.2020.2994762
![]() |
[132] |
W. Liu, Q. Zhang, J. Chen, R. Xiang, H. Song, S. Shu, et al., Detection of COVID-19 in children in early january 2020 in Wuhan, China, N. Engl. J. Med., 382 (2020), 1370–1371. doi: 10.1056/NEJMc2003717
![]() |
[133] | M. Z. Alom, M. Rahman, M. S. Nasrin, T. M. Taha, V. K. Asari, COVID_mtnet: COVID-19 detection with multi-task deep learning approaches, preprint, arXiv: 2004.03747. |
[134] |
L. Brunese, F. Mercaldo, A. Reginelli, A. Santone, Explainable deep learning for pulmonary disease and coronavirus COVID-19 detection from x-rays, Comput. Methods and Programs in Biomed., 196 (2020), 105608. doi: 10.1016/j.cmpb.2020.105608
![]() |
[135] |
L. Ni, F. Ye, M. L. Cheng, Y. Feng, Y. Q. Deng, H. Zhao, et al., Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals, Immunity, 52 (2020), 971–977. doi: 10.1016/j.immuni.2020.04.023
![]() |
[136] | A. Narin, C. Kaya, Z. Pamuk, Automatic detection of coronavirus disease (COVID-19) using x-ray images and deep convolutional neural networks, preprint, arXiv: 2003.10849. |
[137] |
T. Ozturk, M. Talo, E. A. Yildirim, U. B. Baloglu, O. Yildirim, U. R. Acharya, Automated detection of COVID-19 cases using deep neural networks with x-ray images, Comput. Biol. Med., 121 (2020), 103792. doi: 10.1016/j.compbiomed.2020.103792
![]() |
[138] | P. K. Sethy, S. K. Behera, P. K. Ratha, P. Biswas, Detection of coronavirus disease (COVID-19) based on deep features and support vector machine, 2020. |
[139] |
A. Rahman, M. J. Islam, A. Montieri, M. K. Nasir, M. M. Reza, S. S. Band, et al., Smartblock-sdn: an optimized blockchain-sdn framework for resource management in IoT, IEEE Access, 9 (2021), 283 61–283 76. doi: 10.1109/ACCESS.2021.3096125
![]() |
[140] | M. J. Islam, A. Rahman, S. Kabir, A. Khatun, A. Pritom, M. Chowdhury, Sdot-nfv: a distributed sdn based security system with IoT for smart city environments, GUB J. Sci. Eng., 7 (2021), 27–35. |
[141] | M. Ndiaye, A. M. Abu-Mahfouz, G. P. Hancke, Sdnmm—a generic sdn-based modular management system for wireless sensor networks, IEEE Syst. J., 14 (2019), 2347–2357. |
[142] | S. Islam, U. Sara, A. Kawsar, A. Rahman, D. Kundu, D. D. Dipta, et al., Sgbba: an efficient method for prediction system in machine learning using imbalance dataset, Int. J. Adv. Comput. Sci. Appl., 12 (2021). |
[143] | A. Rahman, M. J. Islam, F. A. Sunny, M. K. Nasir, Distblocksdn: a distributed secure blockchain based sdn-IoT architecture with nfv implementation for smart cities, in 2019 2nd International Conference on Innovation in Engineering and Technology (ICIET), (2019), 1–6. |
[144] | M. J. Hossain, M. A. H. Wadud, A. Rahman, J. Ferdous, M. F. Mridha, A secured patient's online data monitoring through blockchain: an intelligent way to store lifetime medical records, in International Conference on Science and Contemporary Technologies (ICSCT), 2021. |
[145] | D. Li, 5G and intelligence medicine—how the next generation of wireless technology will reconstruct healthcare? Precis. Clin. Med., 2 (2019), 205–208. |
[146] | Z. Allam, D. S. Jones, On the coronavirus (COVID-19) outbreak and the smart city network: universal data sharing standards coupled with artificial intelligence (AI) to benefit urban health monitoring and management, in Healthcare, Multidisciplinary Digital Publishing Institute, 8 (2020), 1–9. |
1. | Olusegun Michael Otunuga, Alexandra Yu, Vaccine breakthrough and rebound infections modeling: Analysis for the United States and the ten U.S. HHS regions, 2023, 8, 24680427, 717, 10.1016/j.idm.2023.05.010 | |
2. | Tobhin Kim, Hyojung Lee, Sungchan Kim, Changhoon Kim, Hyunjin Son, Sunmi Lee, Improved time-varying reproduction numbers using the generation interval for COVID-19, 2023, 11, 2296-2565, 10.3389/fpubh.2023.1185854 | |
3. | Andreas Baumann, Søren Wichmann, Lexical innovations are rarely passed on during one’s lifetime: Epidemiological perspectives on estimating the basic reproductive ratio of words, 2024, 19, 1932-6203, e0312336, 10.1371/journal.pone.0312336 | |
4. | Xuan Li, Ling Yin, Kang Liu, Kemin Zhu, Yunduan Cui, Deep-reinforcement-learning-based optimization for intra-urban epidemic control considering spatiotemporal orderliness, 2024, 1365-8816, 1, 10.1080/13658816.2024.2431904 | |
5. | Huaiyu Teng, Toshikazu Kuniya, The Optimal Vaccination Strategy to Control COVID‐19, 2025, 0170-4214, 10.1002/mma.10908 |